You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 16 No. 1, January 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Phenothiazines in Prevention of Psychiatric Hospitalization

IV. Delay or Prevention of Hospitalization—A Reevaluation*

DAVID M. ENGELHARDT, MD; BERNARD ROSEN, MA; NORBERT FREEDMAN, PhD; REUBEN MARGOLIS, PhD

Arch Gen Psychiatry. 1967;16(1):98-101.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS PAPER is the fourth in a series of investigations into the factors influencing hospitalization of schizophrenic outpatients. In the first publication it was shown that chlorpromazine had a marked effect in reducing the incidence of hospitalization among ambulatory chronic schizophrenic Patients.1 Further exploration revealed that although chlorpromazine was highly effective early in treatment, its effectiveness diminished progressively over time, suggesting delay rather than prevention of hospitalization. In contrast to phenothiazine-treated patients, the hospitalization rates for groups of patients treated with placebo were similar, regardless of duration of treatment exposure.2 A review of the literature found a similar consistency in the hospitalization rates reported for placebo-treated patients (25% to 30%),2 suggesting the existence of a finite subgroup of "hospitalization prone" patients in any given group of ambulatory schizophrenic patients. In addition, the consistency in the hospitalization rates of placebo-treated groups suggests . . . [Full Text PDF of this Article]


Author Affiliations

BROOKLYN, NY

From the Psychopharmacology Research Unit, Department of Psychiatry, State University of New York, Downstate Medical Center, Brooklyn.


Footnotes

Submitted for publication May 25, 1966.

Reprint requests to 450 Clarkson Ave, Brooklyn, NY 11203 (Dr. Engelhardt).

Parts I and II of this series were published in the Journal of the American Medical Association1,2 and Part III in the ARCHIVES OF GENERAL PSYCHIATRY.3



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.